Articles with public access mandates - Hang XuLearn more
OverallMRCCancer Research UKNIHRWellcomeEuropean CommissionNIHVersus Arthritis, UKRoyal Society UKGovernment of SpainMelanoma Research AllianceDoDSwedish Research CouncilPancreatic Cancer, UKHHMIHelmholtzBlood Cancer UKEPSRCNKFIDamon Runyon Cancer Research FoundationLung Cancer Research Foundation, USA
Available somewhere: 19
Tracking the evolution of non–small-cell lung cancer
M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ...
New England Journal of Medicine 376 (22), 2109-2121, 2017
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ...
Nature 545 (7655), 446-451, 2017
Mandates: US National Institutes of Health, Versus Arthritis, UK, Cancer Research UK …
Allele-specific HLA loss and immune escape in lung cancer evolution
N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ...
Cell 171 (6), 1259-1271. e11, 2017
Mandates: Versus Arthritis, UK, Cancer Research UK, UK Medical Research Council …
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
S Turajlic, K Litchfield, H Xu, R Rosenthal, N McGranahan, JL Reading, ...
The lancet oncology 18 (8), 1009-1021, 2017
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal
S Turajlic, H Xu, K Litchfield, A Rowan, T Chambers, JI Lopez, D Nicol, ...
Cell 173 (3), 581-594. e12, 2018
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal
S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ...
Cell 173 (3), 595-610. e11, 2018
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal
TJ Mitchell, S Turajlic, A Rowan, D Nicol, JHR Farmery, T O’Brien, ...
Cell 173 (3), 611-623. e17, 2018
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors
FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ...
Immunity 46 (4), 577-586, 2017
Mandates: Blood Cancer UK, Cancer Research UK, UK Engineering and Physical Sciences …
Pervasive chromosomal instability and karyotype order in tumour evolution
TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ...
Nature 587 (7832), 126-132, 2020
Mandates: US Department of Defense, US National Institutes of Health, Helmholtz …
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie, A Rowan, ...
Cancer cell 39 (11), 1497-1518. e11, 2021
Mandates: Versus Arthritis, UK, Cancer Research UK, UK Medical Research Council …
A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation
YH Lo, KS Kolahi, Y Du, CY Chang, A Krokhotin, A Nair, WD Sobba, ...
Cancer discovery 11 (6), 1562-1581, 2021
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Swedish …
Cell of origin influences pancreatic cancer subtype
BM Flowers, H Xu, AS Mulligan, KJ Hanson, JA Seoane, H Vogel, ...
Cancer discovery 11 (3), 660-677, 2021
Mandates: US National Institutes of Health
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
K Litchfield, JL Reading, EL Lim, H Xu, P Liu, M Al-Bakir, YNS Wong, ...
Nature communications 11 (1), 3800, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Representative sequencing: unbiased sampling of solid tumor tissue
K Litchfield, S Stanislaw, L Spain, LL Gallegos, A Rowan, D Schnidrig, ...
Cell reports 31 (5), 2020
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Selection of metastasis competent subclones in the tumour interior
Y Zhao, X Fu, JI Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ...
Nature ecology & evolution 5 (7), 1033-1045, 2021
Mandates: US National Institutes of Health, Versus Arthritis, UK, Cancer Research UK …
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study
X Fu, Y Zhao, JI Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ...
Nature ecology & evolution 6 (1), 88-102, 2022
Mandates: US National Institutes of Health, Versus Arthritis, UK, Cancer Research UK …
Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways
L Spain, A Coulton, I Lobon, A Rowan, D Schnidrig, STC Shepherd, ...
Cancer discovery 13 (6), 1364-1385, 2023
Mandates: US Department of Defense, US National Institutes of Health, Versus Arthritis …
Automated design of paralogue ratio test assays for the accurate and rapid typing of copy number variation
CD Veal, H Xu, K Reekie, R Free, RJ Hardwick, D McVey, AJ Brookes, ...
Bioinformatics 29 (16), 1997-2003, 2013
Mandates: UK Medical Research Council
Selection of metastasis competent subclones in the tumour interior: TRACERx renal
Y Zhao, X Fu, J Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ...
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Publication and funding information is determined automatically by a computer program